BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28363637)

  • 1. DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection.
    Sulyok M; Rückle T; Roth A; Mürbeth RE; Chalon S; Kerr N; Samec SS; Gobeau N; Calle CL; Ibáñez J; Sulyok Z; Held J; Gebru T; Granados P; Brückner S; Nguetse C; Mengue J; Lalremruata A; Sim BKL; Hoffman SL; Möhrle JJ; Kremsner PG; Mordmüller B
    Lancet Infect Dis; 2017 Jun; 17(6):636-644. PubMed ID: 28363637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study.
    Llanos-Cuentas A; Casapia M; Chuquiyauri R; Hinojosa JC; Kerr N; Rosario M; Toovey S; Arch RH; Phillips MA; Rozenberg FD; Bath J; Ng CL; Cowell AN; Winzeler EA; Fidock DA; Baker M; Möhrle JJ; Hooft van Huijsduijnen R; Gobeau N; Araeipour N; Andenmatten N; Rückle T; Duparc S
    Lancet Infect Dis; 2018 Aug; 18(8):874-883. PubMed ID: 29909069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation.
    Murphy SC; Duke ER; Shipman KJ; Jensen RL; Fong Y; Ferguson S; Janes HE; Gillespie K; Seilie AM; Hanron AE; Rinn L; Fishbaugher M; VonGoedert T; Fritzen E; Kappe SH; Chang M; Sousa JC; Marcsisin SR; Chalon S; Duparc S; Kerr N; Möhrle JJ; Andenmatten N; Rueckle T; Kublin JG
    J Infect Dis; 2018 Feb; 217(5):693-702. PubMed ID: 29216395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study.
    McCarthy JS; Lotharius J; Rückle T; Chalon S; Phillips MA; Elliott S; Sekuloski S; Griffin P; Ng CL; Fidock DA; Marquart L; Williams NS; Gobeau N; Bebrevska L; Rosario M; Marsh K; Möhrle JJ
    Lancet Infect Dis; 2017 Jun; 17(6):626-635. PubMed ID: 28363636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates.
    Gómez-Pérez GP; Legarda A; Muñoz J; Sim BK; Ballester MR; Dobaño C; Moncunill G; Campo JJ; Cisteró P; Jimenez A; Barrios D; Mordmüller B; Pardos J; Navarro M; Zita CJ; Nhamuave CA; García-Basteiro AL; Sanz A; Aldea M; Manoj A; Gunasekera A; Billingsley PF; Aponte JJ; James ER; Guinovart C; Antonijoan RM; Kremsner PG; Hoffman SL; Alonso PL
    Malar J; 2015 Aug; 14():306. PubMed ID: 26245196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.
    Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F; Lamsfus Calle C; Löhr SJ; Lalremruata A; Gunasekera A; James ER; Billingsley PF; Richman A; Chakravarty S; Legarda A; Muñoz J; Antonijoan RM; Ballester MR; Hoffman SL; Alonso PL; Kremsner PG
    Malar J; 2015 Mar; 14():117. PubMed ID: 25889522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands.
    van der Plas JL; Kuiper VP; Bagchus WM; Bödding M; Yalkinoglu Ö; Tappert A; Seitzinger A; Spangenberg T; Bezuidenhout D; Wilkins J; Oeuvray C; Dhingra SK; Thathy V; Fidock DA; Smidt LCA; Roozen GVT; Koopman JPR; Lamers OAC; Sijtsma J; van Schuijlenburg R; Wessels E; Meij P; Kamerling IMC; Roestenberg M; Khandelwal A
    Lancet Infect Dis; 2023 Oct; 23(10):1164-1174. PubMed ID: 37414066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with
    Collins KA; Rückle T; Elliott S; Marquart L; Ballard E; Chalon S; Griffin P; Möhrle JJ; McCarthy JS
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30858218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers.
    McCarthy JS; Rückle T; Elliott SL; Ballard E; Collins KA; Marquart L; Griffin P; Chalon S; Möhrle JJ
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.
    Sissoko MS; Healy SA; Katile A; Omaswa F; Zaidi I; Gabriel EE; Kamate B; Samake Y; Guindo MA; Dolo A; Niangaly A; Niaré K; Zeguime A; Sissoko K; Diallo H; Thera I; Ding K; Fay MP; O'Connell EM; Nutman TB; Wong-Madden S; Murshedkar T; Ruben AJ; Li M; Abebe Y; Manoj A; Gunasekera A; Chakravarty S; Sim BKL; Billingsley PF; James ER; Walther M; Richie TL; Hoffman SL; Doumbo O; Duffy PE
    Lancet Infect Dis; 2017 May; 17(5):498-509. PubMed ID: 28216244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ
    Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.
    Murphy SC; Deye GA; Sim BKL; Galbiati S; Kennedy JK; Cohen KW; Chakravarty S; Kc N; Abebe Y; James ER; Kublin JG; Hoffman SL; Richie TL; Jackson LA
    PLoS Pathog; 2021 May; 17(5):e1009594. PubMed ID: 34048504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.
    Sulyok Z; Fendel R; Eder B; Lorenz FR; Kc N; Karnahl M; Lalremruata A; Nguyen TT; Held J; Adjadi FAC; Klockenbring T; Flügge J; Woldearegai TG; Lamsfus Calle C; Ibáñez J; Rodi M; Egger-Adam D; Kreidenweiss A; Köhler C; Esen M; Sulyok M; Manoj A; Richie TL; Sim BKL; Hoffman SL; Mordmüller B; Kremsner PG
    Nat Commun; 2021 May; 12(1):2518. PubMed ID: 33947856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprotective Antimalarial Activity of P218 against Plasmodium falciparum: A Randomized, Placebo-Controlled Volunteer Infection Study.
    Chughlay MF; El Gaaloul M; Donini C; Campo B; Berghmans PJ; Lucardie A; Marx MW; Cherkaoui-Rbati MH; Langdon G; Angulo-Barturen I; Viera S; Rosanas-Urgell A; Van Geertruyden JP; Chalon S
    Am J Trop Med Hyg; 2021 Feb; 104(4):1348-1358. PubMed ID: 33556040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of
    Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers.
    van Wolfswinkel ME; Langenberg MCC; Wammes LJ; Sauerwein RW; Koelewijn R; Hermsen CC; van Hellemond JJ; van Genderen PJ
    Malar J; 2017 Nov; 16(1):457. PubMed ID: 29126422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.